Discontinuation report ACT RANITIDINE

Last updated on 2020-05-14 History
Report ID 115082
Drug Identification Number 02248571
Brand name ACT RANITIDINE
Common or Proper name RANITIDINE 300MG TAB
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-05-08
Actual discontinuation date 2020-05-08
Remaining supply date 2020-05-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-05-14 English Compare
v2 2020-05-14 French Compare

Showing 1 to 2 of 2